← Back to Search

Innovative Taping Technique for Catheter Complications

N/A
Waitlist Available
Led By Pete Kovatsis, MD
Research Sponsored by Boston Children's Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up until the tape is dislodged- approximately 15 seconds
Awards & highlights

Study Summary

This trial will assess the effectiveness of 3 taping methods to keep IVs from being pulled from the skin. 6 measurements per subject will be taken to measure resistance to force.

Who is the study for?
This trial is for Boston Children's Hospital employees who haven't been part of the study before, don't have fragile or damaged skin near their elbow crease (antecubital fossa), aren't excessively hairy there, and don't have allergies to adhesive materials.Check my eligibility
What is being tested?
The study is testing three different ways to tape IV catheters: a new method being developed, the current BCH Emergency Department method, and the Chevron method. It measures how well each can keep an IV in place against forces pulling it in different directions.See study design
What are the potential side effects?
Since this trial involves taping on top of the skin without actual IV insertion, side effects are minimal but may include minor skin irritation or allergic reactions if one has sensitivity to the tape used.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~until the tape is dislodged- approximately 15 seconds
This trial's timeline: 3 weeks for screening, Varies for treatment, and until the tape is dislodged- approximately 15 seconds for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
The Force (Newtons) Required to Dislodge an IV Catheter Secured by the Chevron, BCH ED, and Novel Taping Methods Using a Force Gauge in a 90 degrees direction.
The Force (Newtons) Required to Dislodge an IV Catheter Secured by the Chevron, BCH ED, and Novel Taping Methods Using a Force Gauge in the retrograde direction.

Trial Design

2Treatment groups
Active Control
Group I: Retrograde Directional TestActive Control3 Interventions
Subjects during the Retrograde Directional Test will have the three taping methods placed on their left and/or right antecubital fossa region to superficially secure an IV catheter (i.e., the catheter will be placed on top of the participant's skin and not in the vein but will be taped as if the catheter was placed intravenously). Six total measurements will be obtained of which three will be using the Retrograde Directional Test (i.e., each taping method will undergo testing for each directional method). The order of placing the different taping methods and the direction testing will be randomized.
Group II: 90 Degrees Directional TestActive Control3 Interventions
Subjects during the 90 Degrees Directional Test will have the three taping methods placed on their left and right antecubital fossa region, superficially taping an IV catheter (i.e., the catheter will be placed on top of the participant's skin and not in the vein but will be taped as if the catheter was placed intravenously). Six total measurements will be obtained of which three will be using the 90 Degrees Directional Test (i.e., each taping method will undergo testing for each directional method). The order of placing the different taping methods and the direction testing will be randomized.

Find a Location

Who is running the clinical trial?

Boston Children's HospitalLead Sponsor
761 Previous Clinical Trials
5,579,698 Total Patients Enrolled
Pete Kovatsis, MDPrincipal InvestigatorBoston Children's Hospital

Media Library

Retrograde Directional Test Clinical Trial Eligibility Overview. Trial Name: NCT05948878 — N/A
Retrograde Directional Test 2023 Treatment Timeline for Medical Study. Trial Name: NCT05948878 — N/A
Displaced Catheter Research Study Groups: Retrograde Directional Test, 90 Degrees Directional Test
Displaced Catheter Clinical Trial 2023: Retrograde Directional Test Highlights & Side Effects. Trial Name: NCT05948878 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

May I enroll in this clinical research program?

"A total of 35 adults aged 18-65 who have experienced a displaced catheter are required for this trial. Notably, applicants must be employed by Boston Children's Hospital to qualify."

Answered by AI

Does this research trial accept participants over the age of eighty-five?

"According to the rules of this trial, 18 is the youngest age possible for participation and 65 marks the upper limit."

Answered by AI

What opportunities are available for individuals to join the current clinical trial?

"Affirmative. According to clinicaltrials.gov, recruitment for this medical trial is still in progress and set to begin on July 28th 2023 with its last update occuring on August 9th of the same year. The experiment requires 35 participants from a single location."

Answered by AI

What is the enrollment capacity for this medical experiment?

"Affirmative. Clinicaltrials.gov indicates that this trial, which was initially advertised on July 28th 2023, is presently recruiting prospective participants. 35 volunteers are needed from a single medical centre for the study to proceed."

Answered by AI
~19 spots leftby Apr 2025